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Abstract: O-glycosylation of mammalian proteins is one of the important posttranslational 
modifications. We applied a support vector machine (SVM) to predict whether Ser or Thr is 
glycosylated,  in  order  to  elucidate  the  O-glycosylation  mechanism.  O-glycosylated  sites 
were  often  found  clustered  along  the  sequence,  whereas  other  sites  were  located 
sporadically.  Therefore,  we  developed  two  types  of  SVMs  for  predicting  clustered  and 
isolated  sites  separately.  We  found  that  the  amino  acid  composition  was  effective  for 
predicting  the  clustered  type,  whereas  the  site-specific  algorithm  was  effective  for  the 
isolated type. The highest prediction accuracy for the clustered type was 74%, while that for 
the  isolated  type  was  79%.  The  existence  frequency  of  amino  acids  around  the  
O-glycosylation sites was different in the two types: namely, Pro, Val and Ala had high 
existence probabilities at each specific position relative to a glycosylation site, especially for 
the isolated type. Independent component analyses for the amino acid sequences around  
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O-glycosylation sites showed the position-specific existences of the identified amino acids 
as independent components. The O-glycosylation sites were preferentially located within 
intrinsically disordered regions of extracellular proteins: particularly, more than 90% of the 
clustered O-GalNAc glycosylation sites were observed in intrinsically disordered regions. 
This  feature  could  be  the  key  for  understanding  the  non-conservation  property  of  
O-glycosylation, and its role in functional diversity and structural stability. 
Keywords:  protein  O-glycosylation;  mucin-type;  posttranslational  modification;  support 
vector  machine;  clustered  and  isolated  glycosylation  sites;  intrinsically  disordered; 
extracellular protein; non-conservation property 
 
1. Introduction 
Glycan, a carbohydrate chain, is considered the third life chain after DNA and protein [1]. Glycans 
bind  to  proteins or lipids,  and more than 50% of the mammalian proteins are glycosylated [2] to 
acquire  structural  stability  and  function  as  well  as  the  biodiversity  of  organisms.  Abnormal 
carbohydrate chain modification occurs in several serious diseases such as familial tumoral calcinosis 
[3,4], Tn syndrome [5,6], IgA nephropathy [7–9], coronary artery disease [10,11], and tumor formation 
and metastasis [12–14]. 
The two major types of protein glycosylation in eukaryotes are N-linked and O-linked glycosylation. 
N-linked glycans are attached to the amide nitrogens of asparagine (Asn) side chains in the consensus 
sequences Asn-Xaa-Ser or Asn-Xaa-Thr, where Xaa represents any amino acid residue except proline 
(Pro) [15,16]. O-linked glycans are attached to the hydroxyl group of serine (Ser) or threonine (Thr) 
side  chains  [17].  O-linked  glycosylation  (O-glycosylation)  encompasses  several  different  types  of 
glycosylation,  such as  O-GalNAc,  O-GlcNAc,  O-Fuc, O-Glc, O-Man, and O-Xyl glycosylation. In 
eukaryotes,  the  most  common  O-glycosylation  is  O-GalNAc  glycosylation,  or  mucin-type  
O-glycosylation. In the mucin-type O-glycosylation, not all Ser or Thr residues are glycosylated, and no 
specific  consensus  sequence  has  been  identified  so  far.  One  characteristic  of  the  mucin-type  
O-glycosylations is the formation of clusters within repeated amino acid sequences, termed tandem 
repeats, which are rich in Ser or Thr residues [18–20]. Many glycoproteins contain one or more mucin-
like domains, typically rich in Pro, Ser, and Thr residues, producing discrete regions in the entire 
molecule that are heavily decorated with mucin-type O-glycosylations [21].  
On  the  basis  of  statistical  analysis  of  mucin-type  O-glycosylation  sites  and  data  on  GalNAc-T  
(N-acetylgalactosamine  transferase),  the  following  general  rules  apply  regarding  mucin-type  
O-glycosylation  [22]:  (1)  it  is  tissue  specific  (there  are  different  GalNAc-T  with  overlapping  but 
different specificities, and these GalNAc-T have different tissue-specific expression patterns); (2) it is 
mainly a post-translational and postfolding event (therefore, only surface-exposed Ser and Thr residues 
are glycosylated); and (3) it shows a primary sequence preference, which is different for Ser and Thr 
(Thr appears to be glycosylated more efficiently than Ser). Moreover, in a previous analysis of the 
structural context of mucin-type O-glycosylation sites by using the structural information on amino 
acid sequences of mucin-type O-glycoprotein from the Protein Data Bank (PDB) [23], 14 of 86 protein Int. J. Mol. Sci. 2010, 11                       
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sequences were represented by structures in PDB. Of these 14 structures, two were represented twice in 
all 12 non-redundant structures. All sites were found in coil or turn regions located near the N- or  
C-termini of the protein, in linker regions between domains, or in coil regions connecting secondary 
structure elements. Ser and Thr residues annotated as mucin-type O-glycosylation are less likely to be 
precisely conserved among mammalian protein homologs and more likely to be surface-exposed than 
Ser or Thr residues without this annotation. 
Regarding  non-mucin-type  O-glycosylation,  O-GlcNAc-type  glycosylation  has  recently  attracted 
attention; it modifies eukaryotic nuclear and cytosolic proteins  and is as dynamic and possibly  as 
abundant as Ser or Thr phosphorylation. O-GlcNAc glycans are attached to the hydroxyl group of Ser 
or Thr residues. The functions of O-GlcNAc proteins are known for cytoskeletal proteins and their 
regulatory  proteins,  such  as  viral  proteins,  nuclear-pore  and  nuclear-oncogene  proteins,  RNA 
polymerase II catalytic subunit, and numerous transcription factors. Despite their functional diversity, 
all these proteins are also phosphoproteins [24]. 
Proteins with partially or fully intrinsically disordered (ID) structures have been well investigated in 
the past few years and are found mostly in eukaryotes. They are frequently involved in key biological 
processes such as cell cycle control, transcriptional and translational regulation, membrane fusion and 
transport,  and  signal  transduction  [25–28].  Several  characteristics  of  ID  structures  have  been  
elucidated [29,30]: (1) sequence repetitions consisting of a shorter sequence pattern are often contained 
in ID regions [31]; (2) sequence conservation is extremely poor in ID, because ID regions have higher 
evolution rates than structural domains [32]; (3) most ID regions exist in linkers connecting domains 
and/or  in  terminal  tails,  but  some  are  inserted  in  structural  domains  [33];  (4)  the  frequency  of 
intrinsically disordered proteins (IDPs) is higher in eukaryotes than in prokaryotes [34]; (5) most IDPs 
localize  to  the  nucleus  [34];  and  (6)  protein  phosphorylation,  another  type  of  
post-translational  modification,  predominantly occurs  in  ID regions [35].  Currently,  some of these 
characteristics are known to be similar to O-glycosylation. 
In this study, to elucidate the O-glycosylation mechanism, we first applied a support vector machine 
(SVM)  [36]  to  predict  whether  a  Ser  or  Thr  residue  is  glycosylated. Similar  statistical  machine 
learning approaches for the prediction of the mucin-type O-glycosylation site of have been reported 
[23,37]. A pioneering work by Julenius et al. [23] used a layered neural network for prediction. The 
results led to the conclusion that the bulk properties are the main factor for O-glycosylation, as bulk 
average properties including amino acid composition gave the best prediction. There are other reports 
which pointed out the position specific properties of amino acids around O-glycosylation sites: for 
example, high existence ratios of proline (Pro) at −1 and +3 relative to O-glycosylation sites [38]. One 
of the objectives of this study was to identify the crucial properties of the protein for the sites to be  
O-glycosylated, based on performance of  machine learning. O-glycosylated sites  were  often found 
clustered along the sequence, whereas others sites were located sporadically. Therefore, we chose the 
strategy to classify the O-glycosylation sites into two types, i.e., the clustered and isolated types, and to 
separately  determine  the  essential  properties,  and  see if they differ from  each other. We obtained 
mammalian protein sequence data with O-glycosylation site information from UniProt [39], developed 
two types of SVMs for predicting clustered and isolated sites separately, and calculated the existence 
frequencies of amino acids around O-glycosylation sites for the two types to estimate the existence Int. J. Mol. Sci. 2010, 11                       
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probabilities of amino acids at each position relative to the glycosylation sites. We also conducted an 
independent component analysis (ICA) of the amino acid sequences to elucidate whether the position-
specific existences are independent. Finally, we found that O-glycosylation is preferentially located 
within ID regions of extracellular proteins. So far as we are aware, no reports have hitherto discussed 
O-glycosylation in relation to ID regions or IDPs. 
2. Results 
2.1. Prediction by SVM 
SVM was trained for each clustered or isolated type of mucin-type O-glycosylation separately. The 
exact definitions of the clustered and isolated types of O-glycosylations are given in Section 4.2. The 
input to SVM was information on a protein sequence of a fixed length including the prediction target 
site at the center. Two types of information were used: one was the amino acid sequence encoded by 
sparse coding, which distinguished all 20 types of amino acids, while the other was the amino acid 
composition of the sequence. Figure 1 shows the prediction accuracy obtained by using either sequence 
or  composition  information  as  the  input  to  SVM  for  the  clustered  or  isolated  type  of  
O-glycosylation. 
Figure  1.  Prediction  accuracies  for  the  clustered  and  isolated  types  of  mucin-type  
O-glycosylation in various sequences varying in length (window size, Ws ) from three to 55. 
Amino acid sequence or composition information  was used as the input to SVM. The 
crosses  and  circles  indicate  the  prediction  accuracies  obtained  by  using  the  sequence 
information and composition information, respectively. The clustered and isolated types are 
shown in red and blue, respectively. 
 
 
First, we focused on the results obtained by using sequence information. The prediction accuracy for 
the clustered type increased according to the window size (Ws) up to about Ws = 31, with the highest 
value 74% obtained at Ws = 51. On the other hand, for the isolated type, the accuracy remained almost 
constant, including at Ws = 3. The highest accuracy was 79% obtained at Ws = 41. Therefore, the Int. J. Mol. Sci. 2010, 11                       
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sequence  information  up  to  the  15th  nearest  neighbor  was  effective  for  predicting  clustered 
glycosylation, and isolated glycosylation was primarily affected by closer neighbors. 
Next,  we  compared  the  results  of  the  sequence  information  analysis  with  those  obtained  using 
composition information. For the clustered type, the accuracy and Ws dependency with the composition 
information were similar to those with the sequence information. However, for the isolated type, the 
accuracy decreased according to Ws when the input was composition. 
The  difference  between  the  two  types  of  trained  SVMs  was  demonstrated  by  comparing  their 
prediction  accuracies  for  both  clustered  and  isolated  types.  Figure  2(a),(b)  shows  the  prediction 
accuracies  using  the  two  SVMs  for  the  clustered  and  isolated  types,  respectively.  The  input  was 
sequence information. From the results shown in Figure 2, each SVM was specialized for the type used 
in the training. 
Figure 2. (a) Prediction accuracies of the two SVMs for the clustered glycosylation. The 
crosses and circles represent the prediction obtained using the SVM trained by the clustered 
and  isolated  type,  respectively.  The  input  was  the  sequence  information.  
(b) Prediction accuracies of the two SVMs for the isolated glycosylation. The crosses and 
circles  represent  the  prediction  obtained  using  the  SVM  trained  by  the  isolated  and 
clustered type, respectively. 
(a)                 (b) 
 
 
These results indicated that site-specific information of the amino acid residues was effective for 
predicting isolated glycosylation, whereas only the gross composition up to about the 15th neighbor 
affected clustered glycosylation. 
2.2. Existence Frequency of Amino Acids around O-Glycosylation Sites 
According to the previous results, it is likely that glycosylation biosynthesis between clustered and 
isolated types is different, and the site-specific existence of some amino acids affects the glycosylation, 
especially for the isolated type. Therefore, any motif can be expected from the combination of such 
amino acid existences.  
The existence ratio or probability was calculated for 20 types of amino acids at a relative position 
from the glycosylation site for clustered and isolated glycosylations separately. As a typical example of Int. J. Mol. Sci. 2010, 11                       
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the  results,  Figure  3(a)  shows  the existence ratio of proline (Pro) at  each relative position within  
Ws = 31 around the clustered positive, isolated positive, and negative Ser and Thr residues. Pro has a 
high ratio at −1 and +3 relative to the O-glycosylation site [38]. In the figure, the high peak can be 
noted at −1 only for isolated glycosylation and at +3 for both types. The peak at −1 leads to the high 
prediction accuracy even at Ws = 3 for the isolated type shown in Figure 1. 
Similarly, for valine (Val), Figure 3(b) shows very sharp peaks of 16% both at −3 and +8 only for 
isolated glycosylation. Alanine (Ala) had peaks at −6 and +5, again only for isolated glycosylation 
(Figure  3(c)).  On  the  contrary,  cysteine  (Cys)  residues  were  rarely  observed  near  clustered 
glycosylation sites. In summary, a high site-specific existence of certain amino acids was especially 
observed for isolated glycosylation. 
Figure  3.  (a)  Existence  ratios  of  Pro  at  each  position  for  clustered  positive,  isolated 
positive, and negative Ser or Thr sites (indicated by red crosses, blue crosses, and pink 
triangles, respectively). Existence ratios of Val (b) and Ala (c) shown in a similar style. 
(a)                (b) 
 
(c) 
 
2.3. Independence of the Amino Acid Existences 
ICA was applied for the amino acid sequence around a glycosylated site to elucidate whether each 
amino acid existence correlates with or is independent of each other. Figure 4 shows two examples of 
the obtained independent components for the isolated type. Int. J. Mol. Sci. 2010, 11                       
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Figure  4.  Independent  components  of  the  amino  acid  sequence  around  the  isolated 
glycosylation sites, corresponding to the high existence probability of (a) Pro at −1, and  
(b) Pro at +3. The horizontal axis indicates 20 amino acids and a null, and the vertical axis 
indicates  the  relative  position  to  a  glycosylation  site  and  ranges  from  −3  to  +3.  The 
gradation of each box shows the existence ratio of each amino acid at each position. 
(a)             (b) 
 
 
Figure 4 shows the well-known high probabilities of Pro at −1 and +3. Supplemental Figure S1 
shows the newly found Val at −3 and Ala at +2 as independent components. This finding means that 
the  amino  acids  exist  in  a  certain  position  independently  and  affect  isolated  glycosylation.  Other 
components also possess each high probability element. The probability of Pro was also high at +2, −2, 
−3, and +1 (shown in descending order of probability). 
Figure S2 shows two components for the clustered glycosylation. Figure S2(a) shows that Pro at +3 
had a remarkably high probability for this type as well. However, most components did not show high 
probability compared with those obtained for the isolated type (Figure S2(b)). 
2.4. Occurrence of O-GalNAc Glycosylation in Domains or Intrinsically Disordered Regions  
Structural domains and ID regions of mucin-type O-glycoproteins (O-GalNAc) were analyzed using 
DICHOT [40,41] to determine the relationship between O-glycosylation and ID regions. All residues 
were binary classified into structural domains and ID regions. Further, 107 mammalian mucin-type  
O-glycoproteins were taken from the UniProt database (Release 14.0). The results of DICHOT were 
directly downloadable for 62 human proteins, whereas those for 45 non-human proteins were newly 
calculated.  Table  1  shows  the  frequencies  of  O-glycosylation  in  relation  to  ID  regions.  The  total 
numbers of all amino acid residues in the 107 proteins and their ID regions were 45,962 and 14,028, 
respectively.  Thus,  the  existence  ratio  of  ID  regions  in  the  107  O-glycoproteins  was  30.5% 
(14,028/45,962).  On  the  other  hand,  the  numbers  of  all  O-glycosylation  sites  in  the  107  
O-glycoproteins and O-glycosylation sites in their ID regions were 465 and 399, respectively. Thus, the 
existence ratio of ID regions in the O-glycosylated sites was 85.8% (399/465). 
The existence  ratio  of  O-glycosylation  sites  in  ID  regions  was 2.84% (399/14,028), which was 
substantially  higher  (2.8-fold)  than  that  of  O-glycosylation  sites  in  the  107  O-glycoproteins 
(465/45,962  =  1.01%).  On  the  contrary,  the  existence  ratio  of  O-glycosylation  sites  in  structural 
domains was 0.21% (66/31,934). Int. J. Mol. Sci. 2010, 11                       
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When  we  calculated  the  O-glycosylation  ratio  over  Ser  and  Thr  sites  as  a  reference,  the  total 
numbers  of  Ser  and  Thr  residues  in  the  107  proteins  and  their  ID  regions  were  7228  and  2779, 
respectively.  Thus,  the  O-glycosylation  ratio  in  ID  regions  was  14.4%  (399/2779),  which  was 
substantially  higher  (2.2-fold)  than  that  in  the  107  O-glycoproteins  (465/7228  =  6.43%).  On  the 
contrary, the O-glycosylation ratio in structural domains was 1.48% (66/4449). 
When  we  distinguished  between  clustered  and  isolated  O-glycosylation  sites,  there  were  283 
(2.02%)  and  116  (0.83%)  sites,  respectively,  in  ID  regions.  The  existence  ratios of  ID  regions  in 
clustered and isolated O-glycosylated sites were 91.0% and 75.3%, respectively. 
In brief, O-glycosylation occurs more frequently in ID regions than in structural domains, and this 
tendency is more remarkable for clustered glycosylation. 
Table 1. Frequencies of occurrence of O-GalNAc glycosylations at clustered, isolated, and 
total glycosylation sites in ID regions. The total numbers of Ser or Thr residues, and the 
total numbers of amino acid residues are also shown for reference. 107 proteins were taken 
from UniProt 14.0, and ID regions were obtained from DICHOT [40,41].  
  Number of 
sites in ID 
Total number of 
sites in 107 proteins 
Ratio to be in ID 
(%) 
O-linked 
sites 
Clustered  283  311  91.0 
Isolated  116  154  75.3 
Total  399  465  85.8 
Ser/Thr sites  2,779  7,228  38.4 
All sites in 107 proteins  14,028  45,962  30.5 
Figure  5  shows  examples  of  mucin-type  O-glycoproteins.  Six  sites  of  coagulation  factor  XII 
(UniProt ID: FA12_HUMAN) of secreted protein [42] were modified by mucin-type O-glycosylation. 
In addition, glycophorin-A (UniProt ID: GLPA_HUMAN) of cell membrane protein [43,44], plasma 
protease C1 inhibitor (UniProt ID: IC1_HUMAN) of secreted protein [45], and Ig -1 chain C region 
(UniProt ID: IGHA1_HUMAN) of immunoglobulin were O-glycosylated at 16, seven, and five sites, 
respectively. The results of 62 human proteins are shown in Supplemental Figure S3. 
These results support the hypothesis that many mucin-type O-glycoproteins are glycosylated for 
clustered modifications as clusters in ID regions. This is based on the examination of individual cases 
revealing the clustering of most mucin-type O-glycoproteins in ID regions (Figures 5 and S3) and 
nearly all of the small number of the clustered mucin-type O-glycosylation sites in structural domains 
(Figure S3) were very close to the boundary with ID regions. CSF2_HUMAN serves as an example of 
the latter case (Figure S3): O-GalNAc is added to 27 Thr located in a structural domain, but right next 
to the ID region that extends to residue 26 (Figure S3). Furthermore, most of the isolated mucin-type 
O-glycosylation sites also fell in ID regions (Figure S3), while a majority of those in structural domains 
were located in loop regions (e.g., the O-glycosylation site in APOH_HUMAN, Figure S3). 
 Int. J. Mol. Sci. 2010, 11                       
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Figure 5. Glycosylation sites plotted along with the distinction between structural domains 
and  ID  regions  of  human  glycoproteins.  The  light  blue  and  red  regions  correspond  to 
structural  domains  and  ID  regions,  respectively, and the blue and orange dots  indicate 
mucin-type  O-linked  (GalNAc)  and  N-linked  sites,  respectively.  (a)  FA12_HUMAN: 
coagulation factor XII with O-linked (GalNAc) modifications at T299, T305, S308, T328, 
T329  and  T337,  and  N-linked  (GlcNAc)  modifications  at  N249  and  N433.  
(b) GLPA_HUMAN: glycophorin-A with O-linked sites at S21, T22, T23, T29, S30, T31, 
S32,  T36,  S38,  S41,  T44,  T52,  T56,  S63,  S66  and  T69,  and  N-linked  site  at  N45.  
(c) IC1_HUMAN: plasma protease C1 inhibitor with O-linked sites at T48, S64, T71, T83, 
T88, T92 and T96, and N-linked sites at N25, N69, N81, N238, N253, N272 and N352.  
(d) IGHA1_HUMAN: Ig -1 chain C region with O-linked sites at S105, S111, S113, 
S119 and S121, and N-linked sites at N144 and N340. 
(a) 
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2.5. Non-Mucin-Type O-Glycosylation 
Eighty-three non-mucin-type glycoproteins, including those with O-GlcNAc, O-Gal, O-Xly, O-Fuc, 
O-Glc, O-HexNAc, and O-Hex modifications, were collected from UniProt database 14.0. ID regions 
of  these  glycoproteins  were  again  identified  using  DICHOT  [40,41].  The  existence  ratios  of  
O-GlcNAc (78.9%) and O-Xly (85.0%) were high in ID regions (Table 2). This high ratio was caused 
by  the  high  Ser  or  Thr  ratio  in  ID  regions  for  O-GlcNAc  (77.1%),  whereas  O-glycosylation 
preferentially occurred in ID regions for O-Xly, similar to that for O-GalNAc glycosylation.  
Clustered  O-glycosylation  sites  were  rarely  found  in  the  non-mucin-type,  compared  with  the  
mucin-type. One rare example was the clustered O-Xly glycosylation sites in SRGN_HUMAN. 
The ratio of Ser or Thr residues for glycosylation was remarkably high in the mucin-type in ID 
regions (399/2779 = 14.4%), compared with the non-mucin-type. Int. J. Mol. Sci. 2010, 11                       
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Table  2.  Frequencies  of  occurrence  of  the  mucin  type  and  non-mucin-type  
O-glycosylations at residue sites in ID regions. The total numbers of Ser and Thr residues 
are also shown for reference. 190 proteins were taken from UniProt 14.0, and ID regions 
were obtained from DICHOT [40,41]. 
O-linked type  Number 
of 
proteins 
Number of sites in 
ID 
Total number of sites 
in the proteins 
Ratio to be in ID 
(%) 
O-linked  Ser/Thr  O-linked  Ser/Thr  O-linked  Ser/Thr 
O-GalNAc  107  399  2,779  465  7,228  85.8  38.4 
O-GlcNAc  28  45  4,076  57  5,287  78.9  77.1 
O-Gal  14  23  376  43  1,365  53.5  27.5 
O-Xyl  20  34  649  40  1,593  85.0  40.7 
O-Fuc  8  1  62  14  572  7.1  10.8 
O-Glc  8  0  91  8  447  0  20.4 
O-HexNAc*  4  3  94  4  136  75.0  69.1 
O-Hex**  1  1  23  1  53  100.0  43.4 
* O-HexNAc (O-GalNAc or O-GlcNAc) 
** O-Hex (O-Gal or O-Glc) 
3. Discussion 
According to the finding that O-GalNAc glycosylation sites often clustered along the sequence, we 
classified the O-glycosylation sites into clustered and isolated types using a simple criterion. The SVM 
prediction indicated that the amino acid composition was effective for the clustered type, whereas the 
site-specific  algorithm  was  effective  for  the  isolated  type.  The  highest  prediction  accuracy  of  the 
clustered type was 74%, while that of the isolated type was 79%. Moreover, more than 90% of the 
clustered O-GalNAc glycosylation sites were located in ID regions. In the isolated type, some amino 
acid residues were observed at high frequencies at certain positions relative to O-glycosylation sites 
(Pro at −1 and +3, Val at −3 and +8, and Ala at −6 and +5). Addition of ID region information to the 
SVM input improved the prediction accuracy only slightly, implying that amino acid composition as an 
input to an SVM provides most information on ID propensity. 
Previously [23], O-GalNAc glycosylation sites were predicted by using a layered neural network; 
this  study  indicated  that  bulk  average  properties  including  amino  acid  composition  give  the  best 
prediction.  This  is  the  property  of  clustered  glycosylation  sites,  which  constitutes  the  majority  of  
O-GalNAc glycosylation sites (Table 1). The non-conservation of glycosylation sites they discussed is 
the result of a high fraction of ID regions and generally low conservation of ID regions [40]. In another 
report  [38],  O-glycosylation  sites  were  classified  into  multiple  and  isolated  types,  roughly 
corresponding to the clustered and isolated types, respectively, in this paper. However, their criterion 
differed from ours: O-glycosylation sites were defined as multiple when there was at least one more 
glycosylation  site  within  the  tenth-nearest  neighbor.  They  found  high  frequencies  of  Ser  and  Thr 
around multiple glycosylation sites, and proposed the use of this property for predicting the multiple 
type. Further, they indicated high site-specific frequencies of Pro at −1 and +3 for the isolated type, Int. J. Mol. Sci. 2010, 11                       
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which  is  consistent  with  the  present  results.  However,  they  concluded  that  the  finding  was  not 
sufficiently useful for prediction and did not consider ID regions. 
The  four  examples  of  O-GalNAc  glycosylation  (Figure  5)  illustrate  the  high  frequency  of  
O-GalNAc  glycosylation  sites  in  ID  regions:  all  of  the  O-linked  glycosylation  sites  in  the  figure 
belonging to both clustered and isolated types fall in ID regions identified by the DICHOT system. In 
predicting the clustered type of O-GalNAc glycosylation, the amino acid composition near the sites 
was  more  effective  than  sequence  information  (Figure  1).  Interestingly,  this  type  of  O-linked 
glycosylation is mostly located in ID regions and rarely in structural domains (Table 1). As ID regions 
generally have a skewed amino acid composition without specific sequence characteristics [33,46], the 
current finding makes sense because the characteristic amino acid composition of ID regions is likely 
to be a good predictor of the clustered type of O-linked glycosylation. The finding that addition of  
ID  region  information  to  SVM  input  does  not  drastically  improve  the  accuracy  of  prediction  
supports this idea. 
For the isolated type of O-GalNAc glycosylation, however, amino acid sequence information is a 
better predictor than amino acid composition (Figure 1). In this type, 75% of the sites fall into ID 
regions,  much  higher  than  the  average  fraction  of  ID  regions  in  O-GalNAc  glycosylated  proteins 
(30.5%),  while  the  remaining  25%  are  located  in  structural  domains  (Table  1).  The  small  but 
significant  fraction  in  structural  domains  partially  explains  the  sequence  finding:  certain  sequence 
characteristics are needed for this type of O-linked glycosylation site to be located at the molecular 
surface. The finding that Pro at −1 and +3 occur at high frequency indicates that Pro working as a 
breaker of -helix and -sheet is important for the site to accommodate O-GalNAc glycosylation.  
O-GalNAc glycosylation sites of the isolated type are also often found in ID regions very close to the 
boundary of structural domains. In such cases too, sequence characteristics in the vicinity are likely to 
be crucial for making the sites available to O-linked glycosylation. 
In both mucin (O-GalNAc) and non-mucin types of O-linked glycosylation (O-GlcNAc and all the 
rest), O-glycosylation occurs post-translationally (i.e., after protein folding) [22]. In this discussion, we 
first  limited  our  attention  to  mucin-type  and  the  three  most  prevalent  non-mucin-type  O-linked 
glycosylations, namely O-GlcNAc, O-Gal, and O-Xyl (Table 2). The table shows that ID regions are 
generally preferred irrespective of the types of O-linked glycosylation, consistent with the view that 
enzymes that add these types of O-linked glycosylation recognize structural features of proteins. Quite 
possibly, O-linked glycans of these types are attached to residues in ID regions to prevent protease 
degradation of glycosylated proteins. Increased O-GlcNAc modification of human RNA polymerase II 
transcription factor SP1, for instance, deters its degradation in the proteasome [47] and O-GalNAc 
modification of the human CD44 antigen inhibits cleavage of the extracellular domain by specific 
proteases  [48].  On  the  other  hand,  two  other  non-mucin  types  of  O-glycosylations  of  O-Fuc  and  
O-Glc  occur  in  domain  regions.  O-Fuc  and  O-Glc  have  been  found  on  epidermal  growth  factor  
(EGF)-protein domains and have consensus sequences. O-Fuc is attached to the Thr or Ser residue in  
-Cys-Xaa-Xaa-Gly-Gly-Thr/Ser-Cys- [49], and O-Glc is attached to the Ser residue in -Cys-Xaa-Ser-
Xaa-Pro-Cys- [49]. 
The subcellular localizations and consequently cellular functions of O-GalNAc and O-GlcNAc are 
quite different: O-GalNAc is added to proteins sometimes in the endoplasmic reticulum, but mostly in 
the  Golgi  apparatus  [50].  The  modified  proteins  become  either  extracellular  proteins  or  plasma Int. J. Mol. Sci. 2010, 11                       
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membrane proteins with the O-GalNAc glycosylation sites in the extracellular domains. O-GalNAc 
glycosylation  is  tissue  specific,  because  different  GalNAc-Ts  with  overlapping  but  different 
specificities exist and have distinct tissue-specific expression patterns [51]. In contrast, O-GlcNAc 
glycosylation is a reversible modification of cytoplasmic and nuclear proteins and plays a regulatory 
role  in  competition  with  phosphorylation  in  some  proteins  [35,52,53].  Naturally,  the  biological 
significance of O-GalNAc glycosylation is distinct from that of O-GlcNAc. O-GalNAc modification 
affects extracellular processes such as cell adhesion, immunological recognition, and secretion [22], 
while O-GlcNAc modification is involved in transcription regulation, protein trafficking and turnover, 
among others, with a complex dynamic interplay with phosphorylation [54]. It will be interesting to 
investigate how prevention of protein degradation by O-linked glycosylation in ID regions is involved 
in various biological functions. 
4. Materials and Methods 
4.1. Protein Data Sets 
The experimentally validated O-glycosylated Ser and Thr residues in mammalian proteins were 
selected from the UniProt database (Release 12.2) for the analysis in Sections 2.1–2.3. Ninety-eight 
proteins  were  obtained  by  annotation  of  mucin-type  O-glycosylation  by  excluding  “potentially,” 
“probably,” and “by similarity” annotations. There were 452 annotated Ser and Thr sites, and 6004 Ser 
and Thr sites without annotation, which were denoted positive and negative sites, respectively. Further, 
there were several homologs among the 98 proteins. Therefore, as a preliminary analysis, we examined 
whether  the  existence  of  these  homologs  affects  the  SVM-based  prediction  by  selecting  only  one 
protein among the homologs with a similarity threshold down to 0.2. This step did not largely change 
the prediction accuracy obtained by ten-fold cross validation (Section 4.3). Therefore, all 98 proteins 
were used in the study. 
The protein data used for the analysis in Sections 2.4 and 2.5 were obtained from the UniProt 
database  (Release  14.0).  One  hundred  and  seven  proteins  were  obtained  as  showing  mucin-type  
O-glycosylation  (O-GalNAc)  and  83  proteins  were  obtained  as  showing  non-mucin-type  
O-glycosylation  of  O-GlcNAc,  O-Gal,  O-Xly,  O-Fuc,  O-Glc,  O-HexNAc,  and  O-Hex  (Table  2). 
Among the 107 proteins with mucin-type O-glycosylation, 62 were human and 45 were non-human. 
Among the 83 proteins with non-mucin-type O-glycosylation, 38 were human and 45 were non-human. 
4.2. Clustered and Isolated O-Glycosylation Sites 
Many positive sites were densely clustered, whereas others were located sporadically. We defined 
the two types of positive sites as follows: if the nearest neighbor Ser or Thr site on either side was 
glycosylated,  it  was  termed  a  clustered  O-glycosylation  site;  otherwise,  it  was  considered isolated 
(Figure 6). Accordingly, among the 452 positive sites, 307 were clustered and the remaining were 
isolated. Glycoprotein MUCAP_PIG had the highest number of clustered sites, including 31 clustered 
modification sites among 1148 amino acids, and glycoprotein CEL_HUMAN had the highest number 
of  isolated  sites,  including  10  isolated modification sites  among  741 amino acids. These multiple 
isolated  sites  were  caused  by  repeated  segments  of  Thr-Gly-Asp-Ser,  with  glycosylated  Thr  and  
non- glycosylated Ser. Int. J. Mol. Sci. 2010, 11                       
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Figure 6. Example of clustered and isolated O-glycosylation sites. Ser or Thr residues of 
clustered,  isolated,  and  of  non-glycosylated  sites,  are  indicated  in  red,  blue  and  green, 
respectively. 
RNPDNDIRPWPTQAAPPTPVSPRLHVKPQPTTRTPPQSQTPGALPAKSEQ 
GAVPPTGDSGAPPVPPTGDSGALPGNTGLRDQHMAIAWVKRNIAAFGGDA 
The SVM was trained for each type separately. In the predictions, all positive sites were used, and 
the same number of negative sites was randomly selected by uniform probability.  
The input to SVM was a protein sequence including the prediction target site. A sequence of fixed 
length, Ws, was excised from the original protein sequence with a prediction target of a Ser or Thr 
residue at the center. For example, a target site and the first to third nearest-neighbor amino acid 
residues on both sides constitute a sequence of Ws = 7. Ws varied from three to 55 in the predictions. 
Two types of information on the Ws sequence were used as the input. One type of information was 
the amino acid sequence encoded by a sparse coding with 21 bits, which distinguished all 20 types of 
amino acids and a null (outside the protein terminal). Therefore, the amino acid sequence information 
was expressed as a 21(Ws − 1) +2 bits binary vector. The other input information was the amino acid 
composition, which was expressed as a 21-dimensional real value vector.  
4.3. Prediction by SVM 
Radial basis function was used as an SVM kernel, which was given by the following: 
K(x, x’) ~ exp(– x – x’||
2)  (1)  
where  is the kernel parameter. Another parameter was margin size, denoted by C. We used the open 
software package SVM-light. C varied from 0.1 to 100 and  varied from 1.0 ×  10
−4 to 1.0. 
Ten-fold cross-validation was used for the learning and the evaluation to utilize the limited number 
of data fully. In this validation, each protein was grouped into one of 10 groups. Then, all positive sites 
and the same number of negative sites selected from the proteins in the group were used as training and 
validating  samples.  The  performance  was  evaluated  by  the  prediction  accuracy  averaged  over  
10 groups, and C and  with the best performance were selected for each Ws value. 
4.4. Amino Acid Sequence for ICA 
ICA  was  applied  for  an  amino  acid  sequence  of  Ws  =  7  around  the  glycosylation  site  for  the  
307  clustered  and  145  isolated  sites.  Six  amino  acids  except  the  glycosylation  site,  regardless  of 
whether  it  was  Ser  or  Thr,  were  expressed  by  21-bit  sparse  coding  to  form  a  126-dimensional  
binary vector. 
Then, principal component analysis (PCA) was used to reduce the dimensional size, and only the 
top 10 principal components were used for the ICA. Thus, 10 independent components were obtained 
for  each  type.  As  the  original  data  were  encoded  by  sparse  coding,  which  directly  indicates  the 
existence of each amino acid, the value of the vector element corresponded to the existence ratio of 
each amino acid at a certain position. 
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4.5. Binary Prediction of Ordered/Disordered Protein Segments by DICHOT 
Binary classification of protein molecules into structural domains and ID regions was performed by 
using  the  DICHOT  system  [40],  which  was  applied  to  all  the  107  proteins  with  mucin-type  
O-glycosylation and the 83 proteins with non-mucin-type O-glycosylation analyzed in this study. The 
DICHOT system assigns structural domains with similarity to known 3D structures by the method used 
in  the  GTOP  database  [54],  which  is  a  genome  wide  structural  assignment  database.  The  
un-assigned  regions  in  this  process  were  judged  with  a  combination  of  pre-existing  and  newly 
developed programs to discriminate structural domains and ID regions. Among the 107 proteins with 
mucin-type O-glycosylation, the results of DICHOT are available for the 62 human proteins at the web 
site [41], but not for the 45 non-human proteins. In addition, the revised result was used for one human 
protein, CEL_HUMAN, whose sequence length was changed because of an update of UniProt. 
5. Conclusions 
We found that the classification of mucin-type (O-GalNAc) glycosylation into clustered and isolated 
types  is  useful  in  developing  algorithms  to  accurately  predict  O-GalNAc  glycosylation  sites. 
Furthermore, we discovered that most O-GalNAc and O-GlcNAc glycosylation sites are in ID regions. 
We propose that these O-linked glycans protect the ID regions from degradation and are crucial in 
controlling cellular functions. 
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